LMH STRATEGIC SOLUTIONS

Lobbying for INCYTE CORPORATION · Biopharmaceutical Company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Delaware · House · Senate · $70,000.00 income · posted Jan 12, 2026

Lobbying activity 2

Pharmacy

Prescription drug payment reform. Pharmaceutical supply chain.

Medicare/Medicaid

General Medicare and Medicaid Issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.